Industry experts share their perspectives on current trends, challenges, and control strategies to protect growing pigs from influenza A virus in swine (IAV-S) and limit its impact on productivity and profitability.

Are your pigs at risk?

Ingelvac Provenza®: Are Your Pigs At Risk? Video Thumbnail

Tim Loula, DVM, provides a look at the prevalence of IAV-S in growing pigs. We also compare the differing perspectives between veterinarians and producers about the threat of IAV-S.

The real cost of IAV-S

videos/the-real-cost-of-iav-s.title Video Thumbnail

Hear from Clayton Johnson, DVM, about performance loss and the widespread impact of IAV-S on profitability.

Benefits of a live vaccine

Ingelvac Provenza®: Benefits of a Live Vaccine Video Thumbnail

Marie Culhane, DVM, PhD, discusses how to stimulate a good immune response in growing pigs. Market research shows the industry is looking for timely coverage of emerging strains.

Sow versus pig vaccination

Ingelvac Provenza®: Sow versus Pig Vaccination Video Thumbnail

On the fence about when to vaccinate? Jim Lowe, DVM, MS, Dip ABVP (Food Animal), explains the industry’s previous strategy for protecting pigs against IAV-S. Veterinarians overwhelmingly agree that IAV-S vaccination in growing pigs must have an ability to overcome maternal antibodies.

A practitioner's on-farm experience

Ingelvac Provenza®: A Practitioner's On-farm Experience Video Thumbnail

Stephen Patterson, DVM, shares advice for getting a good IAV-S diagnosis, setting expectations, and making sure there’s a way to measure progress.

Cases from the field

Ingelvac Provenza®: Sow versus Pig Vaccination Video Thumbnail

Stephen Patterson, DVM, shares feedback from colleagues in the field about positive Ingelvac Provenza™ results, from increased weight gain to decreased mortality rates.

Thought leader perspectives

Ingelvac Provenza®: Thought Leader Perspectives Video Thumbnail

Industry leaders weigh in on the challenges and control strategies to protect growing pigs against IAV-S.



Are you located within the United States of America?

This is a required field

This website is an international information resource intended for veterinarians who are interested in information about Ingelvac Provenza® and influenza A virus in swine.

While the Internet serves a global community, the pharmaceutical industry is subject to country-specific regulatory considerations. This means that the registration status and approved product label may not be the same in different countries.

INGELVAC Provenza® IS ONLY CURRENTLY LICENCED IN THE UNITED STATES OF AMERICA. Information on this website is derived from the product label in the USA.

By checking the box below, you are declaring and confirming that you are a veterinarian professional and that you have read and understood this disclaimer.

You must accept the terms and conditions and data policy to enter the website

Ingelvac Provenza is a trademark of Boehringer Ingelheim Vetmedica GmbH. © 2018 Boehringer Ingelheim Vetmedica, Inc.